Skip to Content

News Releases

Nov 18 2021
RxSight to Participate in the Ophthalmology Day at BTIG
ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)  RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual Ophthalmology Day at BTIG.
Nov 10 2021
RxSight Reports Third Quarter 2021 Financial Results
ALISO VIEJO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended September 30, 2021.
Oct 27 2021
RxSight to Report Third Quarter 2021 Financial Results on November 10, 2021
ALISO VIEJO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 10, 2021. The company’s management will discuss the results
Sep 09 2021
RxSight Reports Second Quarter 2021 Financial Results
ALISO VIEJO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended June 30, 2021.
Sep 01 2021
RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021
ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial results. In observance of the Rosh Hashanah holiday, the company will now report after the market
Aug 31 2021
RxSight to Participate in the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Healthcare Conference. RxSight’s management is scheduled to present Friday, September 10, 2021, at
Aug 24 2021
RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021 
ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company’s management will discuss the results
Aug 17 2021
RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales
ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice President of U.S. Sales. In this new position, Mr. Everly will lead the continued development and
Aug 10 2021
RxSight Announces Appointments to its Board of Directors
ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of the closing of the Company’s initial public offering on August 3, 2021.
Aug 04 2021
RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option to Purchase Additional Shares
ALISO VIEJO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the closing of its initial public offering of 7,350,000 shares of common stock on August 3, 2021, as well as the partial exercise of the underwriters’ option to purchase an
Displaying 1 - 10 of 11